↓ Skip to main content

Dove Medical Press

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date

Overview of attention for article published in Journal of Hepatocellular Carcinoma, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#13 of 234)
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
2 X users
patent
2 patents

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
79 Mendeley
Title
Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
Published in
Journal of Hepatocellular Carcinoma, January 2019
DOI 10.2147/jhc.s168953
Pubmed ID
Authors

Nicola Personeni, Tiziana Pressiani, Lorenza Rimassa

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 79 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 11%
Researcher 8 10%
Student > Ph. D. Student 7 9%
Student > Doctoral Student 6 8%
Student > Bachelor 6 8%
Other 18 23%
Unknown 25 32%
Readers by discipline Count As %
Medicine and Dentistry 20 25%
Biochemistry, Genetics and Molecular Biology 11 14%
Pharmacology, Toxicology and Pharmaceutical Science 9 11%
Agricultural and Biological Sciences 4 5%
Chemistry 3 4%
Other 6 8%
Unknown 26 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 February 2023.
All research outputs
#4,374,273
of 24,213,557 outputs
Outputs from Journal of Hepatocellular Carcinoma
#13
of 234 outputs
Outputs of similar age
#94,254
of 445,639 outputs
Outputs of similar age from Journal of Hepatocellular Carcinoma
#2
of 5 outputs
Altmetric has tracked 24,213,557 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 234 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,639 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.